Elkhorn Partners’s Gilead Sciences GILD Stock Holding History

Elkhorn Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,650	Closed	-$388K	–	49
2024 Q2	$388K	Buy	5,650 +4,700	+495%	+$314K	0.27%	18
2024 Q1	$70K	Buy	950 +600	+171%	+$46.1K	0.05%	34
2023 Q4	$28K	Sell	350 -550	-61%	-$42.8K	0.02%	43
2023 Q3	$67K	Buy	+900	New	+$69.2K	0.04%	36
2022 Q2	–	Sell	-1,025	Closed	-$61K	–	50
2022 Q1	$61K	Buy	+1,025	New	+$65.5K	0.03%	30
2021 Q3	–	Sell	-500	Closed	-$34K	–	45
2021 Q2	$34K	Hold	500	–	–	0.02%	33
2021 Q1	$32K	Hold	500	–	–	0.02%	35
2020 Q4	$29K	Buy	+500	New	+$30.2K	0.02%	29
2020 Q2	–	Sell	-125	Closed	-$9K	–	40
2020 Q1	$9K	Sell	125 -3,775	-97%	-$261K	0.01%	38
2019 Q4	$253K	Buy	3,900 +400	+11%	+$26K	0.15%	29
2019 Q3	$222K	Hold	3,500	–	–	0.13%	29
2019 Q2	$236K	Buy	+3,500	New	+$230K	0.14%	26
2018 Q3	–	Sell	-3,800	Closed	-$269K	–	31
2018 Q2	$269K	Buy	+3,800	New	+$268K	0.16%	25
2017 Q3	–	Sell	-3,000	Closed	-$212K	–	40
2017 Q2	$212K	Buy	+3,000	New	+$200K	0.13%	35

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Elkhorn Partners's GILD Position: Q3 2024 in Review

Elkhorn Partners sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 5,650 shares — an estimated $388K sold.

Elkhorn Partners first reported a position in GILD in Q2 2017 and held it in 14 quarters. The position peaked at $388K in Q2 2024. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

Elkhorn Partners reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
Elkhorn Partners sold 5,650 Gilead Sciences shares in Q3 2024, an estimated $388K.
Elkhorn Partners first reported a position in Gilead Sciences in Q2 2017 and held it in 14 quarters.
Elkhorn Partners's Gilead Sciences position peaked at $388K in Q2 2024.
1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Elkhorn Partners's 13F filing for Q3 2024, filed 13 Nov 2024.